Hugo Solvet

Hugo Solvet is an Executive Director in Equity Research specializing in Medical Technologies & Services. Hugo has a strong track record, with their team consistently ranking #1 or Runner Up in the Institutional Investor Survey from 2020 to 2023. Prior to their current role, Hugo gained valuable experience at Bryan, Garnier & Co and Amundi, where Hugo focused on European Diagnostics, Medical Technology, Biotechnology sectors, and Healthcare. Hugo holds a Master's degree in Finance from Toulouse School of Management and has previous academic experience at Université de Montréal.